| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely hydrocortisone 25 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone probutate 1 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone 2% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone acetate 0.5% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone acetate 2.5% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone sodium succin 1000mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone sodium succin 100mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone sodium succin 500mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone 2.5% lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone sodium succin 250mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely hydrocortisone 5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely hydrocortisone 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone 10 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely hydrocortisone butyrate 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Acetic acid 20 mg/mL and hydrocortisone 10 mg/mL ear solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Acetic acid, glacial + hydrocortisone 2%vv/1%wv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Benzoyl peroxide + hydrocortisone 50mg/5mg lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chloroxylenol + hydrocortisone + pramoxine hydrochloride 1mg/10mg/10mg drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clioquinol + hydrocortisone 3%ww/0.5%ww cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clioquinol + hydrocortisone 3%ww/0.5%ww lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clioquinol + hydrocortisone 30mg/10mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Colistin sulfate + hydrocortisone acetate + neomycin sulfate 0ns/10mg/0ns solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hexachlorophene + hydrocortisone + menthol 5mg/5mg/1.25mg topical cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/5mg/1.6mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone+neomycin sulfate+polymyxin b sulphate 10mg/5ns/10000unt suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/7.5mg/10000unt suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/7.5mg/1000unt solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone + polymyxin b 5mg/10000unt drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone acetate + neomycin sulfate + polymyxin b sulfate 5mg/3.5mg/10000unit cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone acetate + pramoxine hydrochloride 1%wv/1%wv lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clioquinol+flumethasone pivalate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing benzoyl peroxide and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ascorbic acid- and clioquinol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Colistin sulfate + hydrocortisone acetate + neomycin sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chloroxylenol + hydrocortisone + pramoxine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing hydrocortisone and neomycin sulfate and polymyxin B sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ciprofloxacin 0.2% + hydrocortisone 1% otic solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone acetate+neomycin sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Diiodohydroxyquinoline- and hydrocortisone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Clioquinol + hydrocortisone + pramoxine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone acetate 50mg/mL injection suspension 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone sodium succinate 1000mg/vial powder for injection 8mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone acetate 50mg/mL injection suspension 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone sodium succin 500mg/vial powder for injection 4mL vial (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone 1% / Pramocaine 1% foam enema (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone sodium succinate 250mg/vial powder for injection 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone sodium phosphate 50mg/mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone sodium succinate 100mg/vial powder for injection 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone acetate + pramoxine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fluocinolone acetonide+clioquinol 0.025%/3% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fluocinolone acetonide+clioquinol 0.025%/3% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone 1% aqueous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone acetate + pramoxine hydrochloride 1%ww/1%ww aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone acetate 10 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone acetate 25 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone acetate + pramoxine hydrochloride 2.5%ww/1%ww lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone acetate + pramoxine hydrochloride 2.5%ww/1%ww ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone cypionate |
Is a |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone sodium phosphate |
Is a |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone sodium succinate (substance) |
Is a |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone buteprate |
Is a |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone butyrate |
Is a |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone valerate |
Is a |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone acetate |
Is a |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ciprofloxacin+hydrocortisone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing acetic acid and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing betamethasone and clioquinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical hydrocortisone adverse reaction |
Causative agent (attribute) |
True |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Topical compound hydrocortisone preparation adverse reaction |
Causative agent (attribute) |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to hydrocortisone (finding) |
Causative agent (attribute) |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical hydrocortisone allergy |
Causative agent (attribute) |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical compound hydrocortisone preparation allergy |
Causative agent (attribute) |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocortisone adverse reaction (disorder) |
Causative agent (attribute) |
True |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Hydrocortisone sensitivity |
Causative agent (attribute) |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cinchocaine + hydrocortisone (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Lignocaine 5% / Hydrocortisone acetate 0.275% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing calamine and clioquinol and zinc oxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Free cortisol |
Is a |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cortisol derivative |
Is a |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Serum cortisol |
Is a |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cortisol, free measurement (procedure) |
Component |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Cortisol, challenge tests (procedure) |
Component |
True |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| 9am cortisol measurement |
Component |
True |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Midnight cortisol measurement |
Component |
True |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cortisol day curve |
Component |
True |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cosyntropin test |
Component |
True |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cortisol measurement, free, urine |
Component |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
| Cortisol measurement (procedure) |
Component |
True |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Urine free cortisol 24 hour assay |
Component |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Serum cortisol measurement (procedure) |
Component |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Urine cortisol titer measurement |
Component |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Plasma cortisol measurement |
Component |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| 24 hour urine cortisol output measurement |
Component |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| 30 minute serum cortisol measurement |
Component |
False |
Hydrocortisone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]